REFERENCES

  1. Williams I. Epidemiology of hepatitis C in the United States. Am Journal of Med, 1999;107:25-9S.
  2. Seef L. Natural history of hepatitis C. Am Journal of Med, 1999;107: 10S-15S
  3. Seef L, Hollinger B, Alter H, et al. Long-term mortality and morbidity of transfusion-
  4. associated non-A, non-B, and type C hepatitis: a National Heart, Lung, and Blood Institute Collaborative Study. Hepatology, 2000;33:455-63.

  5. Davis G, Esteben-Mur R, Rustgi V, et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. NEJM, 1988;339:1493-9.
  6. McHutchinson J, Gordon S, Schiff E, et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. NEJM, 1998;339:1485-92.
  7. Poynard T, Marcellin P, Lee S, et al. Randomized trial of interferon a2b plus ribavirin for 48 weeks or for 24 weeks versus interferon 2a plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. The Lancet, 1998;352:142632.
  8. Keefe E, Hollinger B, and the Consensus Interferon Study Group. Therapy of hepatitis C: Consensus interferon trials. Hepatology, 1997;26(Suppl 1):10 1 S-1075.
  9. Ruiz-Moreno M, Leal-Orozco A, Millan A. Hepatitis C virus infection in children. Journal of Hepatology, 1991;31(Suppl 1):124-9.
  10. Jonas M. Hepatitis C infection in children. NEJM, 1999;341:912-13.
  11. Vogt M, Lang T, Frosner G, et al. Prevalence and clinical outcome of hepatitis C infetion in children who underwent cardiac surgery before the implementation of blood-donor scrc(ming. NEJM, 1999;341:866-70.
  12. Aach R, Yomtovian R, Hack M. Neonatal and pediatric posttransfusion hepatitis C: A look back and a look forward. Pediatrics, 2000;105:836-42.
  13. Christensson B, Weibe T, Akesson A, Widell A. Interferon-a and ribavirin treatment of hepatitis C in children with malignancy in remission. Clin Infect Dis, 2000;30:5856.
  14. International Conference on Harmonisation; E-11: Clinical Investigation of Medicinal Products in the Pediatric Population. July 2000.